Why the study?
To evaluate predictors of electrical storm, including chronic total occlusion in an infarct-related coronary artery, in patients with prior MI and ICDs.
Does the presence of a non-revascularized infarct-related artery chronic total occlusion predict electrical storm in patients with prior MI and an ICD?
Does the presence of a non-revascularized infarct-related artery chronic total occlusion predict electrical storm in patients with prior MI and an ICD?
In patients with prior MI and an ICD, a non-revascularized infarct-related artery CTO is an independent predictor of electrical storm, which can be combined with prior ventricular arrhythmias and LVEF ≤38% to stratify risk.
IRACTO was associated with higher electrical storm risk in post-MI ICD patients; hypothesis-generating and requires prospective validation before clinical use.
Funding Acknowledgements Type of funding sources: None. Aims To evaluate predictors of electrical storm (ES), including chronic total occlusion in an infarct-related coronary artery (infarct-related artery CTO, IRACTO), in a cohort of patients with prior myocardial infarction (MI) and implantable cardioverter-defibrillators (ICD). Methods Multicenter observational cohort study including 643 consecutive patients with prior MI and a first ICD implanted between 2005 and 2018 at three tertiary hospitals. All the patients included in the study had undergone a diagnostic coronary angiography before ICD implantation. The variable prior ventricular arrhythmias (VA+) was positive in patients with secondary prevention ICDs and in those with at least one appropriate ICD therapy after primary prevention implantation. Results During a median follow-up of 42 months 59 patients (9%) suffered ES. The presence of at least one IRACTO not revascularized (IRACTO-NR) was associated with a significantly higher cumulative incidence of ES (14.5% vs 4.8%, p<0.001). IRACTO-NR maintained a significant association with ES after adjustment for potential confounders (HR 2.3, p=0.005) and was an independent predictor of ES together with VA+ and LVEF. The best cut-off of LVEF to predict ES was ≤38%. A risk-prediction model based on IRACTO-NR, VA+ and LVEF≤38% identified three categories of ES risk (low, intermediate and high), with progressively increasing cumulative incidence of ES (2.2%, 9% and 20%). Conclusion In a cohort of patients with prior MI and ICD, IRACTO-NR is an independent predictor of ES. A new risk-prediction model allowed the identification of three categories of risk, with potentially important clinical implications.
No takes yet. Share an insight, caveat, or question.
Faga et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: